Catalyst Pharmaceutical Partners Inc., of Coral Gables, Fla., said the European Commission granted orphan designation to CPP-115, a GABA aminotransferase inhibitor, in West syndrome (infantile spasms...Effimune SAS, of Nantes, France, said it signed a funding agreement with the European Commission for its TRIAD (Tolerance Restoration in Autoimmune Diseases) project, which will receive a total of €3 million (US$4 million) in funding over a three-year period

Cellartis AB, of Gothenburg, Sweden, a division of Cellectis SA, said it would become a partner in TissueGEN, a multinational stem cell project funded by the European Commission

Cellartis AB, of Gothenburg, Sweden, a division of Cellectis SA, said it would become a partner in TissueGEN, a multinational stem cell project funded by the European Commission

Furiex Pharmaceuticals Inc., of Morrisville, N.C., said the European Commission (EC) endorsed a positive opinion adopted by the Committee for Human Medicinal Products Oct. 18, 2011, regarding Prilogy (dapoxetine) 30-mg and 60-mg doses for use in premature ejaculation in men between the ages of 18 and 64

Amsterdam Molecular Therapeutics NV, of Amsterdam, the Netherlands, reported that rather than approve the Committee for Human Medicinal Products' recommendation to deny marketing authorization for Glybera (alipogene tiparvovec), the European Commission's Standing Committee of the European Parliament requested additional information before it votes on the matter

1 million (US$3.96 million) in funding from the Walloon Region and the European Commission's Seventh Framework Programme (FP7...Ltd., of Osaka, Japan, said the European Commission has adopted the European Medicines Agency Committee for Medical Products for Human Use's opinion on pioglitazone-containing medicines, including Actos

Ltd., of Osaka, Japan, said the European Commission has adopted the European Medicines Agency Committee for Medical Products for Human Use's opinion on pioglitazone-containing medicines, including Actos

The goal is then to license promising candidates to other pharmaceutical companies for advanced clinical development and commercialization...In other news, GSK and Human Genome Sciences Inc., of Rockville, Md., said they started dosing in BLISS-SC, a new Phase III trial of Benlysta (belimumab) administered subcutaneously once weekly to autoantibody-positive adults with active systemic lupus erythematosus (SLE

A decision from the European commission is expected in February

Astellas Pharma Europe Ltd., a subsidiary of Tokyo-based Astellas Pharma Inc., and Optimer Pharmaceuticals Inc., of San Diego, said the European Commission granted marketing authorization for Dificlir (fidaxomicin) tablets for the treatment of adults with Clostridium difficile infections (CDI), also known as Clostridium difficile-associated diarrhea

Optimer Pharmaceuticals Inc., of San Diego, and Astellas Pharma Europe Ltd., a subsidiary of Tokyo-based Astellas Pharma Inc., said the European Commission granted marketing authorization for Dificlir (fidaxomicin) tablets for the treatment of adults with Clostridium difficile infections (CDI), also known as Clostridium difficile-associated diarrhea

Alexion Pharmaceuticals Inc., of Cheshire, Conn., said the European Commission extended the therapeutic indication for Soliris (eculizumab) in the European Union to include pediatric and adult patients with atypical hemolytic uremic syndrome (aHUS

A decision by the European Commission is expected within three months

A decision by the European Commission is expected within three months

Pfizer Inc., of New York, said the European Commission approved Vyndaqel (tafamidis) to treat transthyretin familial amyloid polyneuropathy (TTR-FAP) in adult patients with Stage I symptomatic polyneuropathy

BioAlliance Pharma SA, of Paris, said the European Commission granted orphan designation for clonidine Lauriad in the prevention of radiotherapy-induced oral mucositis in patients with head and neck cancer...DuoCort Pharma AB, of Helsingborg, Sweden, said the European Commission granted European Marketing Authorization for Plenadren (hydrocortisone, modified-release tablet), an orphan drug for the treatment of adrenal insufficiency in adults

DuoCort Pharma AB, of Helsingborg, Sweden, said the European Commission granted European Marketing Authorization for Plenadren (hydrocortisone, modified-release tablet), an orphan drug for the treatment of adrenal insufficiency in adults

BioAlliance Pharma SA, of Paris, said the European Commission granted orphan designation for clonidine Lauriad in the prevention of radiotherapy-induced oral mucositis in patients with head and neck cancer

The project will be funded primarily by the European Commission Seventh Framework Program